Table 1.
Patient demographics and baseline characteristics (FAS)
| All patients (n = 212) | |
|---|---|
| Age category, n (%) | |
| 18–39 years | 48 (22.6) |
| 40–59 years | 92 (43.4) |
| ≥60 years | 72 (34.0) |
| Male : female, n (%) | 133 : 79 (63 : 37) |
| BMI, n (%) | |
| <25 kg/m2 | 37 (17.5) |
| 25–30 kg/m2 | 73 (34.4) |
| >30 kg/m2 | 102 (48.1) |
| PGA, n (%) | |
| Mild | 61 (28.8) |
| Moderate | 122 (57.5) |
| Severe | 29 (13.7) |
| Duration of psoriasis, n (%) | |
| <2 years | 4 (1.9) |
| 2–5 years | 30 (14.2) |
| >5 years | 178 (84.0) |
| BSA, n (%) | |
| <4% | 93 (43.9) |
| 4%–6% | 56 (26.4) |
| 6%–11% | 38 (17.9) |
| 11%–15% | 11 (5.2) |
| ≥15% | 14 (6.6) |
| mPASI, n (%) | |
| 2–5 | 86 (40.6) |
| 5.1–10 | 91 (42.9) |
| >10 | 35 (16.5) |
| Mean DLQI | 7.8 |
| Localized: widespread distribution of psoriasis, % | 62 : 38 |
BMI, body mass index; BSA, body surface area; DLQI, dermatology life quality index; FAS, full analysis set; mPASI, modified psoriasis and severity index; PGA, physician's global assessment of disease severity.